Feasibility and Acceptability of Butterfly iQ

NACompletedINTERVENTIONAL
Enrollment

1,575

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

March 15, 2024

Study Completion Date

March 15, 2024

Conditions
Pregnancy Related
Interventions
DEVICE

Butterfly iQ

The primary intervention under study is the Butterfly iQ point-of-care ultrasound device, embedded in a larger program of training, iterative ANC service delivery design, and a final program evaluation.

Trial Locations (1)

Unknown

Johns Hopkins Research Project, Blantyre

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

collaborator

Kamuzu University of Health Sciences

OTHER

collaborator

Ministry of Health, Malawi

OTHER_GOV

lead

Jhpiego

OTHER

NCT05054504 - Feasibility and Acceptability of Butterfly iQ | Biotech Hunter | Biotech Hunter